SCHEMBL3477633

SCHEMBL3477633

CNS(=O)(=O)c1ccc(CCC(=O)OC)cc1

nearest known ligand 0.61

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.61
ALDH1A1 P00352 6/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
KDM4E B2RXH2 1/20 0.56
NPC1 O15118 1/20 0.56
GAA P10253 1/20 0.56
HPGD P15428 1/20 0.56
RAB9A P51151 1/20 0.56
LMNA P02545 2/20 0.50
NPSR1 Q6W5P4 1/20 0.50
NLRP3 Q96P20 1/20 0.48
CCR9 P51686 1/20 0.47
HTT P42858 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5489381 0.83 ALDH1A1 (0.71) IDO1ALDH1A1NPC1GAARAB9A
SCHEMBL24032613 0.83 SMN1; SMN2 (0.59) ALDH1A1SMN1; SMN2KDM4ENPC1GAA
SCHEMBL13055884 0.83 IDO1 (0.57) IDO1ALDH1A1SMN1; SMN2KDM4ENPC1
SCHEMBL22922181 0.82 CYP4F2 (0.59) IDO1ALDH1A1LMNAHTT
SCHEMBL343527 0.82 IDO1 (0.56) IDO1ALDH1A1SMN1; SMN2KDM4ENPC1
SCHEMBL2303459 0.82 CA2 (0.65) IDO1ALDH1A1SMN1; SMN2LMNA
SCHEMBL30898772 0.82 IDO1 (0.56) IDO1ALDH1A1SMN1; SMN2KDM4ENPC1
SCHEMBL833553 0.81 IDO1 (0.54) IDO1ALDH1A1SMN1; SMN2KDM4ENPC1
SCHEMBL28713472 0.79 ALDH1A1 (0.57) IDO1ALDH1A1SMN1; SMN2GAALMNA
SCHEMBL3367245 0.79 IDO1 (0.59) IDO1ALDH1A1KDM4ECCR9HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010078393-A1 KINASE INHIBITORS ALLERGAN, INC. (US) 2010-07-08 WO disclosed
EP-2099757-A2 SULFOXIMINES AS KINASE INHIBITORS Allergan, Inc. (US) 2009-09-16 EP disclosed
WO-2008061236-A2 SULFOXIMINES AS KINASE INHIBITORS ALLERGAN, INC. (US) 2008-05-22 WO disclosed